BMJ  2005;331:614 (17 September), doi:10.1136/bmj.38561.633345.8F (published 17 August 2005)

Primary care

Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention

¹ Department of Public Health, Dokuz Eylul University School of Medicine, 35340 Izmir, Turkey, ² International Health Group, Liverpool School of Tropical Medicine, Liverpool L3 5QA, ³ Division of Public Health, University of Liverpool, Liverpool L69 3GB

Objective To investigate whether population based primary prevention (risk factor reduction in apparently healthy people) might be more powerful than current government initiatives favouring risk factor reduction in patients with coronary heart disease (CHD) (secondary prevention).

Design, setting, and participants The IMPACT model was used to synthesise data for England and Wales describing CHD patient numbers, uptake of specific treatments, trends in major cardiovascular risk factors, and the mortality benefits of these specific risk factor changes in healthy people and in CHD patients.

Results Between 1981 and 2000, CHD mortality rates fell by 54%, resulting in 68 230 fewer deaths in 2000. Overall smoking prevalence declined by 35% between 1981 and 2000, resulting in approximately 29 715 (minimum estimate 20 035, maximum estimate 44 675) fewer deaths attributable to smoking cessation: approximately 5035 in known CHD patients and approximately 24 680 in healthy people. Population total cholesterol concentrations fell by 4.2%, resulting in approximately 5770 fewer deaths attributable to dietary changes (1205 in CHD patients and 4565 in healthy people) plus 2135 fewer deaths attributable to statin treatment (1990 in CHD patients, 145 in people without CHD). Mean population blood pressure fell by 7.7%, resulting in approximately 5870 fewer deaths attributable to secular falls in blood pressure (520 in CHD patients and 5345 in healthy people) plus approximately 1890 fewer deaths attributable to antihypertensive treatments in people without CHD. Approximately 45 370 fewer deaths were thus attributable to reductions in the three major risk factors in the population: some 36 625 (81%) in people without recognised CHD and 8745 (19%) in CHD patients.

Conclusions Compared with secondary prevention, primary prevention achieved a fourfold larger reduction in deaths. Future CHD policies should prioritise population-wide tobacco control and healthier diets.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Inequalities in mortality during and after restructuring of the New Zealand economy: repeated cohort studies

Tony Blakely, Martin Tobias, and June Atkinson
BMJ 2008 336: 371-375. [Abstract] [Full Text] [PDF]

Preventing coronary heart disease

Rod Jackson, John Lynch, and Sam Harper
BMJ 2006 332: 617-618. [Extract] [Full Text] [PDF]

Primary prevention of CHD saves more lives than secondary
BMJ 2005 331: 0. [Full Text]

Mortality in relation to smoking: 50 years' observations on male British doctors

Richard Doll, Richard Peto, Jillian Boreham, and Isabelle Sutherland
BMJ 2004 328: 1519. [Abstract] [Full Text] [PDF]

Why heart disease mortality is low in France: the time lag explanation • Commentary: Alcohol and other dietary factors may be important • Commentary: Intrauterine nutrition may be important • Commentary: Heterogeneity of populations should be taken into account • Authors' response

Malcolm Law, Nicholas Wald, Meir Stampfer, Eric Rimm, D J P Barker, Johan P Mackenbach, and Anton E Kunst
BMJ 1999 318: 1471-1480. [Extract] [Full Text] [PDF]

Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius

Gary K Dowse, Hassam Gareeboo, K George M M Alberti, Paul Zimmet, Jaakko Tuomilehto, Anil Purran, Djamil Fareed, Pierrot Chitson, Veronica R Collins, and Farojdeo Hemraj
BMJ 1995 311: 1255-1259. [Abstract] [Full Text]

This article has been cited by other articles:

• Petersson, U., Ostgren, C. J., Brudin, L., Ovhed, I., Nilsson, P. M. (2008). Predictors of successful, self-reported lifestyle changes in a defined middle-aged population: The Soderakra Cardiovascular Risk Factor Study, Sweden. Scand J Public Health 36: 389-396 [Abstract]  
• Setoguchi, S., Glynn, R. J., Avorn, J., Mittleman, M. A., Levin, R., Winkelmayer, W. C. (2008). Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-Year Trend Analysis. J Am Coll Cardiol 51: 1247-1254 [Abstract] [Full text]  
• Blakely, T., Tobias, M., Atkinson, J. (2008). Inequalities in mortality during and after restructuring of the New Zealand economy: repeated cohort studies. BMJ 336: 371-375 [Abstract] [Full text]  
• Geller, J. C., Cassens, S., Brosz, M., Keil, U., Bernarding, J., Kropf, S., Bierwirth, R. A., Lippmann-Grob, B., Schultheiss, H.-P., Schluter, K., Pels, K. (2007). Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. Eur Heart J 28: 3051-3058 [Abstract] [Full text]  
• Perkovic, V., Huxley, R., Wu, Y., Prabhakaran, D., MacMahon, S. (2007). The Burden of Blood Pressure-Related Disease: A Neglected Priority for Global Health. Hypertension 50: 991-997 [Full text]  
• Greenland, P., Lloyd-Jones, D. (2007). Time to End the Mixed and Often Incorrect Messages About Prevention and Treatment of Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol 50: 2133-2135 [Full text]  
• Ford, E. S., Capewell, S. (2007). Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002: Concealed Leveling of Mortality Rates. J Am Coll Cardiol 50: 2128-2132 [Abstract] [Full text]  
• Mackin, P., Bishop, D., Watkinson, H., Gallagher, P., Ferrier, I. N. (2007). Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br. J. Psychiatry 191: 23-29 [Abstract] [Full text]  
• Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., Capewell, S. (2007). Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000. NEJM 356: 2388-2398 [Abstract] [Full text]  
• Messer, K., Pierce, J. P, Zhu, S.-H., Hartman, A. M, Al-Delaimy, W. K, Trinidad, D. R, Gilpin, E. A (2007). The California Tobacco Control Program's effect on adult smokers: (1) Smoking cessation. Tobacco Control 16: 85-90 [Abstract] [Full text]  
• Kabagambe, E. K., Baylin, A., Campos, H. (2007). Nonfatal Acute Myocardial Infarction in Costa Rica: Modifiable Risk Factors, Population-Attributable Risks, and Adherence to Dietary Guidelines. Circulation 115: 1075-1081 [Abstract] [Full text]  
• Assmann, G. (2006). Dyslipidaemia and global cardiovascular risk: clinical issues. Eur Heart J Suppl 8: F40-F46 [Abstract] [Full text]  
• Barter, P. (2006). Options for therapeutic intervention: how effective are the different agents?. Eur Heart J Suppl 8: F47-F53 [Abstract] [Full text]  
• Lyratzopoulos, G (2006). The cost of cardiovascular disease: rising, declining or staying still?. Heart 92: 1361-1362 [Abstract] [Full text]  
• Mcelduff, P, Jaefarnezhad, M, Durrington, P N (2006). American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively. Heart 92: 1213-1218 [Abstract] [Full text]  
• Cutler, D. M., Rosen, A. B., Vijan, S. (2006). The value of medical spending in the United States, 1960-2000.. NEJM 355: 920-927 [Abstract] [Full text]  
• Lynch, J., Davey Smith, G., Harper, S., Bainbridge, K. (2006). Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches. J. Epidemiol. Community Health 60: 436-441 [Abstract] [Full text]  
• Blackstone, E. H. (2006). Thinking beyond the risk factors.. Eur. J. Cardiothorac. Surg. 29: 645-652 [Abstract] [Full text]  
• Jackson, R., Lynch, J., Harper, S. (2006). Preventing coronary heart disease.. BMJ 332: 617-618 [Full text]  
• Kohli, P., Greenland, P. (2006). Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease. JAMA 295: 819-821 [Full text]  
• (2005). Why the Decline in Coronary Death Rates?. Journal Watch Cardiology 2005: 7-7 [Full text]  
• Malik, I. (2005). JournalScan. Heart 91: 1503-1504 [Full text]  
• (2005). Why the Decline in Coronary Death Rates?. JWatch Gastroenterology 2005: 9-9 [Full text]  
• (2005). Why the Decline in Coronary Death Rates?. JWatch General 2005: 5-5 [Full text]  

Rapid Responses:

Read all Rapid Responses

not powerful at all ..

L Sam Lewis
bmj.com, 18 Sep 2005 [Full text]

Prevention is Better than Cure

Navneet Singh
bmj.com, 19 Sep 2005 [Full text]

Cholesterol and blood pressure role in modelling questioned.

Eddie Vos
bmj.com, 21 Sep 2005 [Full text]

Realistic assumptions...

Peter R Bates
bmj.com, 21 Sep 2005 [Full text]

What about the economics?

Adam Jacobs
bmj.com, 23 Sep 2005 [Full text]

Re: not powerful at all ..

Belgin Unal, et al.
bmj.com, 24 Sep 2005 [Full text]

Re: Cholesterol and blood pressure role in modelling questioned.

Belgin Unal, et al.
bmj.com, 24 Sep 2005 [Full text]